论文部分内容阅读
目的为了进一步提高本院治疗2型糖尿病的临床疗效,本文就列吡嗪联合二甲双胍治疗2型糖尿病的临床效果进行了浅显的研究和探讨。方法将本院在2009年12月至2012年12月期间收治的102例2型糖尿病患者随机分为观察组和对照组,两组患者各51例,给予对照组患者服用二甲双胍治疗;给予观察组在二甲双胍的基础上加用列吡嗪治疗,对两组患者的治疗效果进行观察和统计。结果观察组患者的治疗效果要明显优于对照组患者的治疗效果,两组之间的差异具有统计学意义(P<0.05)。结论采用列吡嗪联合二甲双胍治疗新诊断2型糖尿病的临床效果十分理想,有效的提高了治疗效果,提高了患者的生活质量,值得推广。
Objective To further improve the clinical efficacy of treatment of type 2 diabetes mellitus in our hospital, this article on the clinical efficacy of phenazine and metformin in the treatment of type 2 diabetes were briefly studied and discussed. Methods A total of 102 patients with type 2 diabetes treated in our hospital from December 2009 to December 2012 were randomly divided into observation group and control group. 51 patients in each group and control group were treated with metformin. The patients in observation group On the basis of metformin plus pyrazine treatment, the treatment of two groups were observed and statistics. Results The treatment effect of the observation group was significantly better than that of the control group. The difference between the two groups was statistically significant (P <0.05). Conclusion The clinical effect of using pyrazin combined with metformin in the newly diagnosed type 2 diabetes is very good, which effectively improves the therapeutic effect and improves the quality of life of the patients, which is worthy of popularization.